All News

CPHI caught up with Monica Vialpando to discuss developments in the cannabis space and preview her CPHI Frankfurt panel discussion 

In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm...

Provention Bio, Inc. have granted exclusive right of first negotiation to Sanofi in exchange for commercial resources in the United States for the potential approval and launch of monoclonal antibody therapeutic teplizumab.

In this Connect to Frankfurt session, Séverine Fagète, VP, Cell Line Development Services at Selexis (Geneva, Switzerland), and Brandon Brino (Durham, USA), Process Development Scientist and Group Leader at KBI Biopharma, present an overv...

In this Connect to Frankfurt session, Philipp Annecke, Junior Key Account Manager and Heinrich Martens, VP Regulatory Affairs of Fresenius Kabi (Bad Homburg, Germany) present guidances from the Medical Devices Regulation on clinical data evaluatio...

Merck opens their latest commercial manufacturing facility in Martillac, France, boasting rapid development and commercialisation of drug products with streamlined processes and state-of-the-art technology.

In this interview with Jimin Han, Director of Climate Change in Business Strategy Team at Samsung Biologics (Incheon, South Korea), we discuss trends in the global biologics market, the biggest opportunities and challenges for this sector, and the...

Crest Cellulose, an Indian excipient manufacturer, has been acquired by plant-based pharmaceutical excipient provider Roquette in a bid to increase the latter’s presence in the Asia Pacific region.

In this Connect to Frankfurt session, Enric Bosch, Global Third Party manager, Chemicals at Boehringer Ingelheim (Barcelona, Spain), investigates the growing shift towards environmental, social, and governance (ESG) principles and how to put responsibl...

Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why. 

The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility.

UK-based CRO Quanticate is set to partner with Cancer Research UK for the launch of the DETERMINE study focused on testing a range of existing and approved drugs and therapies on rare cancers.

In this Connect to Frankfurt session, Clarissa J. Van Allen, Global Senior Manager, Technology Transfer, Oral Solid Dose at Thermo Fisher Scientific (Des Moines, USA), discusses the value of an effective and efficient technology transfer project in the...

A collaboration between development and manufacturing services company MedPharm and biotech company Mosanna aims to develop and deliver a nasal spray treatment for a form of sleep apnea.

A partnership between Bora Pharmaceuticals and TaiRx, Inc. is expected to support the manufacturing of breakthrough anticancer drug CVM-1118, with two phase II clinical trials to commence.

With our expertise in the chemical and physical modification of Minerals and our customer-oriented philosophy, we are the ideal partner to turn your ideas into reality. Meet us at CPHI stand #110F50!   

These merger partners are pleased to unveil their new common identity today. Three legacies, one company: Axplora. 

Quotient Sciences’ Nottingham and Reading facilities have announced the completion of their facility expansions, providing further capabilities to support their flagship program Translational Pharmaceutics®.

With new drug approvals hitting a record high in 2021 and unprecedented number of out-licensing deals closed in 2020, Korean pharmaceutical companies and CDMO’s are poised for significant market growth [i].

President Biden issues executive order to bolster U.S. biomanufacturing sector.

Leveraging their current mRNA vaccine technology developed during the COVID-19 pandemic, Pfizer have announced the start of phase III trials for a potential mRNA-based influenza vaccine.

Researchers demonstrate results of a promising mRNA therapy for ovarian cancer and muscle wasting caused by cachexia, a condition associated with various types of cancers and chronic diseases.

Taiwan-based CDMO Bora Pharmaceuticals have acquired niche generic drugs developer TWi Pharmaceuticals, expanding their outsourced development and manufacturing services with two additional manufacturing facilities.

For 40 years Pfizer CentreOne has been guiding drug projects to success. Here’s how our services make us an altogether different kind of CDMO: 

Through a collaboration with biotech company Touchlight, Lonza is set to expand their end-to-end offering for mRNA manufacturing with additional DNA raw material sources, including Touchlight’s doggybone DNA. 

UPS Healthcare is growing its European network to deliver patient-critical products on time and at the right temperature 

The malaria vaccine R21/Matrix-M, developed by researchers at Oxford University, has produced encouraging new data for the global effort against the mosquito-borne disease. 

Biopharmaceutical company Takeda and CDMO NextPharma have announced an acquisition agreement in which Takeda will divest from their Asker, Norway manufacturing site, set to be acquired by NextPharma.

New research may provide further evidence of the gut’s role in SARS-CoV-2 infection and disease severity with a molecular link between serotonin-producing cells in the gut and COVID-19 disease severity.

The European Medicines Agency has backed the Nuvaxovid COVID-19 vaccine for adults as a booster shot to other COVID-19 vaccines.

Enzyme replacement therapeutic Xenpozyme has received US FDA approval with an orphan drug designation to treat symptoms of Acid Sphingomyelinase Deficiency, a rare genetic disease.

The pharmaceutical companies behind the leading COVID-19 vaccines are in a legal dispute over intellectual property rights surrounding the mRNA vaccines that were released after emergency use authorization in December 2020.

ChargePoint Technology has acquired PuroVaso, leader in the design, development, and manufacture of single-use containers, handling equipment, and accessories for pharma, biopharma, and life sciences.

With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients.  

Lonza expands solid-state characterisation services for polymorph and solid-state properties of APIs with the addition of X-ray powder diffraction to its portfolio.

Thermo Fisher Scientific’s new Plainville, MA viral vector manufacturing facility has opened, expanding the company's cell and gene therapy capabilities with advancing bioproduction and analytical instrumentation technologies.

Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access.

Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. 

CPHI caught up with Eugene Choi to discuss point-of-care medicine manufacturing ahead of his CPHI Frankfurt presentation

The health body recommended use of treatments by Regeneron and Ridgeback Bio

Catalent Inc. is set to acquire Metrics Contract Services in a USD $475 million bid to expand its high-potent capacities and oral development and manufacturing capabilities by the end of 2022

Both tests have been approved by the US regulator for in vitro diagnostic use  

WuXi AppTec subsidiary and leading CRDMO, WuXi STA, has broken the ground at the site for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware.  

‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public  

Moderna’s novel bivalent vaccine is the first of its kind to be approved by the UK Medicines and Healthcare Products Regulatory Agency in the fight against the COVID-19 pandemic and SARS-CoV-2 variants.

The test can distinguish between monkeypox and other diseases that cause similar symptoms. 

CPHI caught up with Jim Fries to discuss sustainable supply chains ahead of his CPHI Frankfurt panel discussion 

A collaboration between Mayo Clinic and National Resilience Inc. hopes to advance the biomanufacturing and delivery of novel biologic therapeutics for rare and complex conditions. 

China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population.

As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August.   

Researchers across several US institutions will come together to establish a centre for the research and development of antiviral drugs and therapeutics against pandemic-level viruses.

A strategic partnership between WeTrade Group and Jiqing Biomedical Technology hopes to rapidly bring monkeypox virus test kits to market and open antigen test sale channels. 

The $5.4 billion deal marks Pfizer's fourth acquisition in the last nine months

In our latest webinar, ‘Consumer Health Trends – Listening to the Gut’, experts from around the globe came together to cover developments in gut microbiome research, solutions for a healthier gut and how consumers can be more con...

The expansion of Thermo Fisher Scientific’s Grand Island, New York cell culture media manufacturing site offers increased redundant capacity in support of vaccine and biologic therapy development and manufacturing.

A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making. 

GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site.

Researchers in South Korea have developed an electronic tattoo that automatically signals potential health issues. 

Brightseed uses its AI-enabled platform to detect natural bioactives important to human health, also known as ‘nature’s dark matter’ 

The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development. 

Researchers develop method to produce organoid materials for disease and drug development research.

NeoPhore Ltd. have entered a 3-year collaboration with leading cancer centre in New York, USA. 

The CDMO will add two new facilities to support its high potency manufacturing services

Serious concerns have been raised about the quality of landmark Alzheimer’s research, undermining commonly held beliefs about the disease

Nine members of the WHO’s expert committee voted against the designation, while six voted in favour

Drug pricing, generics, investment, innovation - how these trends are shaping the face of Japanese pharma

Sharp hopes teaming up with clinical service provider ClinsChain will open the door to the Chinese market

A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Vicki Stone-Bjarup. 

Monkeypox is unlikely to develop into another pandemic, according to the WHO. But the recent spread of the virus could still be a challenge for the vaccine industry. 

Haleon becomes the world’s biggest consumer health business, but debuted with a lower-than-expected valuation

Fred Hutchinson is sponsoring the Phase 1 trial, while Amazon are contributing scientific and machine learning expertise

TFBS will use Univercells’ scale-X™ carbo mid-scale fixed-bed bioreactor to support GMP viral vector operations 

The latest instalment in the CPHI Podcast Series dives into the world of supplements and explores the impact of COVID-19 on this booming market  

The company has seen a sharp uptick in orders for its oral treatment as monkeypox cases rise globally 

The company says its goal is to reduce greenhouse gas emissions, limit waste, and increase social contributions in its new report

In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ...

Decision by US drug regulator on lecanemab expected by early next year

Company is seeking ‘fair compensation’ for alleged infringement of intellectual property rights relating to the use of mRNA tech to create the Pfizer-BioNTech COVID-19 vaccine

The investment will give Symbiosis greater control over sample testing timelines 

The new plant features flow chemistry and milling technology, as well as reactors up to 3,000 liters

Several countries are stepping up vaccination and testing as monkeypox cases continue to climb

Companies that are further down the road to market are more attractive to investors than those in early development 

The new facility is set to quadruple the company's HQ plasmid DNA capacity 

The UN agency convened a meeting last week to discuss the outbreak 

A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid  

VLA15 is the only Lyme disease vaccine candidate currently in clinical development 

The company has seen demand skyrocket in the region. 

The company's goal is to design and test new vaccines for novel pathogens within 100 days of a potential pandemic threat 

The vaccines have been adapted to target the Omicron variant, which has been the dominant variant globally since the beginning of the year 

A committee will meet next week to discuss issuing the emergency designation.

Evotec and Janssen Pharmaceutica team up to discover novel therapeutic candidates 

The Rwanda site will be the first piece of the company’s African manufacturing network  

Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market.  

Pfizer CentreOne hopeful that collaboration in CDMO space will continue as pandemic eases

In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.

CordenPharma, a full-service CDMO of APIs, Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy. 

The $3.3 billion deal will strengthen GSK’s vaccine pipeline. 

The US, Canada, UK, France, Germany, and Spain are among several countries to purchase vaccine doses. 

Purolite discusses its decision to switch from batch emulsification to Jetting technology 

Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment.  

Engaging an integrated services partner could reduce risk and speed-up the process for drug sponsors.

Engagement-based strategy could increase resilience of pharma supply chain. 

Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. 

Robust oversight linked to increased efficiency and better communication with outsourcing partners. 

The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. 

We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. 

Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. 

Informa Markets colleagues explain the motivations behind CPHI’s rebrand. 

Bora says the acquisition will allow it to rapidly build a presence in the biopharmaceuticals market. 

Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction.   

This year’s event takes place as a SMART model, featuring online learning and networking from May 9-27 and an in-person event from May 17-19. 

The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. 

Astorg has agreed to acquire the CDMO from privately-owned industrial group ICIG 

A special purpose acquisition company (SPAC) focused on absorbing companies that make medicines for the biotech and pharmaceutical industry has launched in Europe.  

The first COVID-19 vaccine plant in Africa is at risk of closure due to lack of demand. 

For a full rundown on tech trends driving the sector, catch these five sessions at Pharmapack 2022 

Supply chain disruptions have become the new normal. Recurring pandemic waves, inflation, trade jitters and a war in Europe have done little to quell C-suite anxieties.  

The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. 

The war in Ukraine has forced companies to suspend or delay clinical trials in the region.

CPHI events are renowned for connecting pharma players from across the supply chain to learn, grow, and conduct business all over the world.